Showing results 1 to 20 of 76
next >
| Issue Date | Title | Author(s) |
| 10-Dec-2020 | 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours | Lythgoe, M; Stebbing, J; Pickford, E; Glasmacher, A; Adriani, M, et al |
| 21-Nov-2014 | A framework for generalized subspace pattern mining in high-dimensional datasets | Curry, EWJ; |
| 1-Oct-2022 | A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer | Hoare, JI; Hockings, H; Saxena, J; Silva, VL; Haughey, MJ, et al |
| 1-Dec-2022 | A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) | Monk, BJ; Parkinson, C; Lim, MC; O'Malley, DM; Wilson, MK, et al |
| 11-Oct-2021 | Activating a collaborative innate-adaptive immune response to control metastasis | Sun, L; Kees, T; Santos Almeida, A; Liu, B; He, X-Y, et al |
| 28-Feb-2017 | Adiposity and cancer at all anatomic sites: an umbrella review of the literature | Kyrgiou, M; Kalliala, I; Markozannes, G; Gunter, M; Paraskevaidis, E, et al |
| 10-Jun-2022 | Cancer therapy approval timings, review speed and publication of pivotal registration trials in the US and Europe from 2010-2019 | Lythgoe, M; Desai, A; Gyawali, B; Savage, P; Warner, JL, et al |
| 14-Jan-2020 | Cancer-specific loss of p53 leads to a modulation of myeloid and T cell responses | Blagih, J; Zani, F; Chakravarty, P; Hennequart, M; Pilley, S, et al |
| 20-Jul-2021 | Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance through STING | Braund, M; Barras, D; Mina, M; Ghisoni, E; Morotti, M, et al |
| 21-Dec-2016 | Challenges and methodology in the incorporation of biomarkers in cancer clinical trials. | Wilhelm-Benartzi, CS; Mt-Isa, S; Fiorentino, F; Brown, R; Ashby, D, et al |
| Dec-2021 | Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer | McNeish, I; |
| 5-Jun-2021 | Chromatin accessibility changes at intergenic regions associate with ovarian cancer drug resistance | Gallon, J; Curry, E; Loomis, E; Martin, N; Brody, L, et al |
| May-2022 | Clonal evolution of ovarian high grade serous carcinoma | McNeish, Iain; Cheng, Zhao; |
| 26-Oct-2022 | Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer | Martins, FC; Couturier, D-L; De Santiago, I; Sauer, CM; Vias, M, et al |
| 13-Mar-2019 | Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium. | Goranova, T; Ennis, D; Piskorz, AM; Macintyre, G; Lewsley, LA, et al |
| 29-Aug-2016 | Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation | Nasser, S; Lazaridis, A; Evangelou, M; Jones, B; Nixon, K, et al |
| 1-Jun-2022 | Deciphering the role of histone modifications in uterine leiomyoma: acetylation of H3K27 regulates the expression of genes involved in proliferation, cell signaling, cell transport, angiogenesis and extracellular matrix formation | Carbajo-Garcia, MC; De Miguel-Gomez, L; Juarez-Barber, E; Trelis, A; Monleon, J, et al |
| 16-May-2020 | Detecting endometrial cancer by blood spectroscopy: a diagnostic cross-sectional study | Paraskevaidi, M; Morais, CLM; Ashton, KM; Stringfellow, HF; McVey, RJ, et al |
| 1-Oct-2020 | Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE) | McNeish, I; Ennis, D; Stronach, E; , et al |
| 21-Oct-2016 | Diagnosis of borderline ovarian tumours by rapid evaporative ionisation mass spectrometry (REIMS) using the surgical intelligent knife (iKnife) | Phelps, DL; Balog, J; El-Bahrawy, M; Speller, A; Brown, R, et al |